MICHAEL HULTIN: Open Payments
NPI 1952866451 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$546 in 20 payments from 9 companies in 2025. Trend: 2023 $200 · 2024 $370 · 2025 $546
Food & beverage: $447Education: $99
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $194 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Amgen Inc. | 3 | $75 |
| GENZYME CORPORATION | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Smith+Nephew, Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
Products named: DUPIXENT, TEZSPIRE, AIRSUPRA, NUCALA, INSPIRE, JOURNAVX.
Industry payments across CA — which companies pay providers there.
